GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Clinical trials for GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for stomach cancer: experimental drug BHB810 enters human trials
Disease control Not yet recruitingThis study tests a new drug called BHB810 in adults with advanced stomach or gastroesophageal junction cancer that has not responded to standard treatments. The drug is given as an IV infusion every two weeks. The main goals are to check safety, find the best dose, and see if it …
Matched conditions: GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: BigHat Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Blood test may personalize Post-Surgery care for stomach cancer patients
Knowledge-focused Not yet recruitingThis study looks at whether a simple blood test that detects tumor DNA can help doctors decide on the best treatment after surgery for people with stage III or IVA stomach or gastroesophageal junction cancer. About 32 participants will have their blood tested at several time poin…
Matched conditions: GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Knowledge-focused
Last updated May 26, 2026 12:04 UTC